Examples of using Genentech in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Genentech integration progressing successfully.
US-specific media enquiries on Roche or Genentech.
Are we at Roche/Genentech really a leader in the field?
A patient's perspective After his fight against cancer, Ali Afghan joined Genentech to make a difference for patients.
Being a subsidiary, Genentech develops and produces the same products as Roche.
This policy applies to all trials run by Roche and its affiliates worldwide,including its US company, Genentech.
Building on this commitment, in 2006 alone, Genentech received eight FDA approvals.
The Genentech Research and Early Development organization(gRED), based in South San Francisco.
Given the rapid progress in integrating Genentech, we expect to see further significant productivity gains next year.
Sales by the Pharmaceuticals Division grew 9% in local currencies(2% in Swiss francs, 17% in US dollars),with Roche Pharmaceuticals advancing 11% and Genentech 9%, while Chugai sales declined 2.
Full-year outlook to be updated to include impact of Genentech transaction and communicated with half-year results.
Genentech and Biogen Idec collaborate on Rituxan in the United States, and Roche markets MabThera in the rest of the world, except Japan, where MabThera is co-marketed by Chugai and Zenyaku Kogyo Co.
David A. Ebersman, currently EVP and Chief Financial Officer, and Steve Juelsgaard, EVP Genentech Secretary and Chief Compliance Officer, will be leaving Genentech.
Since Genentech's founding more than 30 years ago, science and innovation have been the driving force, and an important area of differentiation, behind our efforts to help patients with serious medical diseases" commented Arthur D. Levinson further.
During the visit the delegation was also able to convince Genentech, which has 6,500 employees and is situated on its own DNA-highway„One DNA Way“.
The Genentech merger in 2009 was the transaction that has had the biggest impact on our pharmaceuticals business and in diagnostics, we became the market leader when we acquired Boehringer Mannheim in 1997.
A downside of our unique hub andspoke concept lies in the fact that Genentech and Chugai have to pay quite high taxes in their respective environments.
The Genentech site in California, Roche's North America hub, is home to Genentech Research and Early Development, production facilities and a full array of business functions.
Venclexta/Venclyxto is being developed by AbbVie and Roche andis jointly commercialised by AbbVie and Genentech, a member of the Roche Group, in the US and commercialised by AbbVie outside of the US.
And in Regeneronv Genentech[2013] EWCA Civ93, KitchinLJ had emphasised that it had to be possible to make a reasonable prediction that the invention would work with substantially everything falling within the scope of the claim.
As already announced, the Board of Directors will be proposing that Arthur D. Levinson,Chairman of the Board of Directors of Genentech, and William M. Burns, a member of Roche's Corporate Executive Committee until the end of 2009, be elected as new members.
See Genentech Inc's Patent[1989] RPC 147, which rejected an attempt to challenge the validity of a patent on the ground that the requirements of s.14(5) had not been complied with and that the patent should never therefore have been granted.
In reaction to public discussions about the patent, a spokesperson explained that Genentech would be in favour of strict regulation of the use of chimpanzees for biomedical research however, no statement was made against the patenting of great apes.
The Operational Excellence programme initiated in November 2010 to optimise cost structures and achieve productivity gains,together with further synergies from the Genentech integration, generated savings of 950 million Swiss francs in the first half of 2011.
Roche, which currently owns 55.8% of the Genentech outstanding shares, expects to commence the tender offer within approximately two weeks.
Amgen or Genentech with their billion dollar turnovers and several thousands of employees were founded in the late seventies and early eighties. These companies have often invested more than 15 years in the development and marketing of their products.
First and only selective B-cell therapy provides lasting improvement for rheumatoid arthritis patientsRoche announced todaythat, after priority review, Genentech and Biogen Idec have received US approval for the first and only selective B-cell therapy Rituxan(rituximab, marketed as MabThera in Europe) for the treatment of adult patients with active rheumatoid arthritis RA.
Roche, Genentech and Biogen Idec announced today that REFLEX1, a pivotal Phase III study of MabThera(rituximab), successfully met its primary endpoint in the group of patients with the most difficult-to-treat rheumatoid arthritis RA.
Genentech has submitted a Biologics License Application(BLA) for trastuzumab emtansine to the US Food and Drug Administration(FDA) and Roche will shortly be submitting a Marketing Authorisation Application to the European Medicines Agency EMA.
In December Roche and Genentech filed EU and US marketing applications for pertuzumab for HER2-positive metastatic breast cancer, based on study results which showed that pertuzumab combined with Herceptin and chemotherapy significantly extended progression free survival, compared with Herceptin and docetaxel alone.